Pediatr Blood Cancer . 2009 Dec 8; Toledano H, Yahel A, Cohen IJ, Yaniv I, Stein J Contemporary protocols for the treatment of malignant brain tumors such as medulloblastoma (MB) in children, often involve craniospinal irradiation (CSI) at diagnosis followed by serial courses of high dose chemotherapy and autologous hematopoietic stem cell support.

Ginekol Pol . 2009 Sep; 80(9): 704-7 Postawski K, Romanek K, Wróbel A, Rechberger T Diagnosis of cervical pregnancy depends on ultrasonographic image of the gestational sac within the cervix, rather than histopathologic examination

MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective.

Am J Hematol . 2009 Sep 28; Nakasone H, Kanda Y, Ueda T, Matsumoto K, Shimizu N, Minami J, Sakai R, Hagihara M, Yokota A, Oshima K, Tsukada Y, Tachibana T, Nakaseko C, Fujisawa S, Yano S, Fujita H, Takahashi S, Kanamori H, Okamoto S, The combination of cyclophosphamide and granulocyte-colony stimulating factor (G-CSF) has widely been used to mobilize hematopoietic stem cells (HSCs) for autologous stem cell transplantation (ASCT) for multiple myeloma (MM).

The NMC’s annual Midwifery Conference enjoyed another successful year on October 21 as women, midwives, supervisors and other healthcare professionals gathered to discuss current and future developments in the profession.